OneSource Specialty Pharma Limited announced its participation in the upcoming Jefferies Global Healthcare Conference. The event is scheduled to take place in London from November 16, 2026, to November 19, 2026. Company representatives will engage in discussions covering the business overview, strategy, industry trends, and growth outlook. Notably, no unpublished price sensitive information (UPSI) will be shared during these interactions.
Conference Participation Announced
OneSource Specialty Pharma Limited has confirmed its attendance and participation at the prestigious Jefferies Global Healthcare Conference. This significant industry event will be held in London, commencing on November 16, 2026, and concluding on November 19, 2026. The participation is in line with the company’s ongoing investor engagement activities.
Discussion Focus and Information Disclosure
During the conference, designated representatives from OneSource Specialty Pharma will engage in discussions that aim to provide insights into the company’s current operations and future direction. Key areas of discussion will include the company’s business overview, strategic initiatives, prevailing industry trends, and its projected growth outlook. It is important to note that the company has emphasized that no unpublished price sensitive information (UPSI) is slated for disclosure during these discussions.
Regulatory Compliance and Record Keeping
This intimation is provided as part of the company’s commitment to transparency and compliance. The company requests that this notification be taken on record by all relevant stakeholders.
Source: BSE
